Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity

(2019) Juliane Medler et al.   Cell Death & Disease

Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling

(2019) Simone Füllsack et al.   Cell Death & Disease

Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target

(2019) Juliane Medler et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins

(2017) Juliane Kums et al.   mAbs

Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK

(2013) H.-Y. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dimerization of LT R by LT 1 2 is necessary and sufficient for signal transduction

(2013) J. Sudhamsu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)

(2009) Hilka Rauert et al.   JOURNAL OF BIOLOGICAL CHEMISTRY